Salvage regimens before ASCT
| Salvage regimen . | |
|---|---|
| Brentuximab/bendamustine | 26 (39%) |
| Brentuximab/gemcitabine | 15 (22%) |
| Gemcitabine/vinorelbine | 10 (15%) |
| Ifosfamide/vinorelbine | 9 (13%) |
| Brentuximab | 8 (12%) |
| Ifosfamide/carboplatin/etoposide | 6 (9%) |
| Ifosfamide/gemcitabine/vinorelbine | 4 (6%) |
| Brentuximab/nivolumab | 4 (6%) |
| Gemcitabine/vinblastine/liposomal doxorubicin | 1 (1%) |
| Bendamustine/gemcitabine/vinorelbine | 1 (1%) |
| Other | 6 (9%) |
| Salvage regimen . | |
|---|---|
| Brentuximab/bendamustine | 26 (39%) |
| Brentuximab/gemcitabine | 15 (22%) |
| Gemcitabine/vinorelbine | 10 (15%) |
| Ifosfamide/vinorelbine | 9 (13%) |
| Brentuximab | 8 (12%) |
| Ifosfamide/carboplatin/etoposide | 6 (9%) |
| Ifosfamide/gemcitabine/vinorelbine | 4 (6%) |
| Brentuximab/nivolumab | 4 (6%) |
| Gemcitabine/vinblastine/liposomal doxorubicin | 1 (1%) |
| Bendamustine/gemcitabine/vinorelbine | 1 (1%) |
| Other | 6 (9%) |